RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Opiant Pharmaceuticals Stock

Opiant Pharmaceuticals Net Income 2025

Opiant Pharmaceuticals Net Income

3.27 M USD

Ticker

OPNT

ISIN

US6837501039

WKN

A2AFQ6

In 2025, Opiant Pharmaceuticals's profit amounted to 3.27 M USD, a -58.36% increase from the 7.85 M USD profit recorded in the previous year.

The Opiant Pharmaceuticals Net Income history

YEARNET INCOME (undefined USD)
2026e1.39
2025e3.27
2024e7.85
2023e-17.92
2022e-39.71
20213.01
2020-1.86
201911.59
2018-21.2
20171.38
20166.58
2015-7.81
2014-7.04
2013-11.48
2012-9.18
2011-12.42
2010-9.44
2009-2.02
20080.03
2007-0.02
2006-0.03
2005-0.03

Opiant Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Opiant Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Opiant Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Opiant Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Opiant Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Opiant Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Opiant Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Opiant Pharmaceuticals’s growth potential.

Opiant Pharmaceuticals Revenue, EBIT and net profit per share

DateOpiant Pharmaceuticals RevenueOpiant Pharmaceuticals EBITOpiant Pharmaceuticals Net Income
2026e342.2 M undefined18.76 M undefined1.39 M undefined
2025e193.9 M undefined19.49 M undefined3.27 M undefined
2024e78.18 M undefined-21.32 M undefined7.85 M undefined
2023e38.05 M undefined-31.52 M undefined-17.92 M undefined
2022e9.18 M undefined-42.43 M undefined-39.71 M undefined
202147.79 M undefined5.16 M undefined3.01 M undefined
202029.63 M undefined-2.24 M undefined-1.86 M undefined
201940.52 M undefined10.91 M undefined11.59 M undefined
201813.98 M undefined-21.19 M undefined-21.2 M undefined
201711.76 M undefined1.54 M undefined1.38 M undefined
201618.45 M undefined7.09 M undefined6.58 M undefined
20159.9 M undefined-7.74 M undefined-7.81 M undefined
20141.55 M undefined-6.9 M undefined-7.04 M undefined
20130 undefined-11.3 M undefined-11.48 M undefined
20120 undefined-8.81 M undefined-9.18 M undefined
20110 undefined-12.34 M undefined-12.42 M undefined
20100 undefined-9.44 M undefined-9.44 M undefined
20090 undefined-2.02 M undefined-2.02 M undefined
20080 undefined-10,000 undefined30,000 undefined
20070 undefined-20,000 undefined-20,000 undefined
20060 undefined-30,000 undefined-30,000 undefined
20050 undefined-30,000 undefined-30,000 undefined

Opiant Pharmaceuticals stock margins

The Opiant Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Opiant Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Opiant Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Opiant Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Opiant Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Opiant Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Opiant Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Opiant Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Opiant Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Opiant Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Opiant Pharmaceuticals Margin History

Opiant Pharmaceuticals Gross marginOpiant Pharmaceuticals Profit marginOpiant Pharmaceuticals EBIT marginOpiant Pharmaceuticals Profit margin
2026e81.03 %5.48 %0.41 %
2025e81.03 %10.05 %1.69 %
2024e81.03 %-27.27 %10.04 %
2023e81.03 %-82.84 %-47.11 %
2022e81.03 %-462.22 %-432.62 %
202181.03 %10.79 %6.3 %
202079.08 %-7.56 %-6.28 %
201980.95 %26.92 %28.6 %
201889.34 %-151.57 %-151.65 %
201788.01 %13.1 %11.73 %
201681.03 %38.43 %35.66 %
201581.03 %-78.18 %-78.89 %
201481.03 %-445.16 %-454.19 %
201381.03 %0 %0 %
201281.03 %0 %0 %
201181.03 %0 %0 %
201081.03 %0 %0 %
200981.03 %0 %0 %
200881.03 %0 %0 %
200781.03 %0 %0 %
200681.03 %0 %0 %
200581.03 %0 %0 %

Opiant Pharmaceuticals Aktienanalyse

What does Opiant Pharmaceuticals do?

Opiant Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of medications for the treatment of addiction disorders and acute medical needs. The company was founded in 2006 and is headquartered in Santa Monica, California. Since its inception, Opiant Pharmaceuticals Inc. has developed innovative drugs that can help mitigate the effects of addiction disorders and meet the demand for emergency medications. The company follows a clear business model based on the implementation of clinical trials and the commercialization of the resulting medications. One of Opiant Pharmaceuticals Inc.'s core areas is the development of medications that can be used in the context of opioid overdoses. One of the best-known products is Narcan Nasal Spray, an emergency medication that can be used in cases of opioid overdose. The product is fast, easy, and safe to use and has proven to be highly effective in practice. In addition to the development of medications for the treatment of opioid overdoses, Opiant Pharmaceuticals Inc. has also developed medications for the treatment of alcohol dependence. One of the best-known medications is Nalmefene, sold as Selincro in Europe and Canada. The medication is used in combination with behavioral counseling and has proven to be an effective treatment option for patients with alcohol dependence. Another division of Opiant Pharmaceuticals Inc. is the development of medications for acute medical needs. This includes medications such as Fentanyl Nasal Spray, which can be used for the treatment of acute pain. Another medication is the opioid analgesic Oxycodone combined with Naltrexone, which is used for the treatment of moderate to severe pain. In addition, Opiant Pharmaceuticals Inc. also has a wide range of products in the pipeline that are in various stages of development and clinical trials. These include medications for the treatment of methamphetamine and cocaine dependence, as well as for postoperative nausea and vomiting. The company actively invests in research and development and is constantly striving to develop innovative and effective medications that can help minimize the effects of addiction disorders and meet medical needs. Overall, Opiant Pharmaceuticals Inc. has established itself as a leading provider of medications for the treatment of addiction disorders. The company has an impressive track record in drug development and aims to offer effective treatment options to patients around the world. With a strong pipeline of products and a dedicated leadership team, Opiant Pharmaceuticals Inc. is well-positioned to continue growing in the coming years and establish itself as a leading provider of medications for the treatment of addiction disorders. Opiant Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Opiant Pharmaceuticals's Profit Margins

The profit margins of Opiant Pharmaceuticals represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Opiant Pharmaceuticals's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Opiant Pharmaceuticals's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Opiant Pharmaceuticals's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Opiant Pharmaceuticals’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Opiant Pharmaceuticals stock

How much profit has Opiant Pharmaceuticals made this year?

Opiant Pharmaceuticals has made 3.27 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -58.36% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Opiant Pharmaceuticals publish its earnings?

Opiant Pharmaceuticals publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Opiant Pharmaceuticals?

The profits of Opiant Pharmaceuticals are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Opiant Pharmaceuticals?

You can learn more about the earnings of Opiant Pharmaceuticals by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Opiant Pharmaceuticals pay?

Over the past 12 months, Opiant Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Opiant Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Opiant Pharmaceuticals?

The current dividend yield of Opiant Pharmaceuticals is .

When does Opiant Pharmaceuticals pay dividends?

Opiant Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Opiant Pharmaceuticals?

Opiant Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Opiant Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Opiant Pharmaceuticals located?

Opiant Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Opiant Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Opiant Pharmaceuticals from 1/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/28/2025.

When did Opiant Pharmaceuticals pay the last dividend?

The last dividend was paid out on 1/28/2025.

What was the dividend of Opiant Pharmaceuticals in the year 2024?

In the year 2024, Opiant Pharmaceuticals distributed 0 USD as dividends.

In which currency does Opiant Pharmaceuticals pay out the dividend?

The dividends of Opiant Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Opiant Pharmaceuticals

Our stock analysis for Opiant Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Opiant Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.